These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 35062943)

  • 1. Deep cfDNA fragment end profiling enables cancer detection.
    Zhitnyuk YV; Koval AP; Alferov AA; Shtykova YA; Mamedov IZ; Kushlinskii NE; Chudakov DM; Shcherbo DS
    Mol Cancer; 2022 Jan; 21(1):26. PubMed ID: 35062943
    [No Abstract]   [Full Text] [Related]  

  • 2. Non-invasive lung cancer diagnosis and prognosis based on multi-analyte liquid biopsy.
    Chen K; Sun J; Zhao H; Jiang R; Zheng J; Li Z; Peng J; Shen H; Zhang K; Zhao J; Zhu S; Wang Y; Yang F; Wang J
    Mol Cancer; 2021 Jan; 20(1):23. PubMed ID: 33514352
    [No Abstract]   [Full Text] [Related]  

  • 3. Targets, pitfalls and reference materials for liquid biopsy tests in cancer diagnostics.
    Geeurickx E; Hendrix A
    Mol Aspects Med; 2020 Apr; 72():100828. PubMed ID: 31711714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multidimensional Fragmentomics Enables Early and Accurate Detection of Colorectal Cancer.
    Cao Y; Wang N; Wu X; Tang W; Bao H; Si C; Shao P; Li D; Zhou X; Zhu D; Yang S; Wang F; Su G; Wang K; Wang Q; Zhang Y; Wang Q; Yu D; Jiang Q; Bao J; Yang L
    Cancer Res; 2024 Oct; 84(19):3286-3295. PubMed ID: 39073362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of fragment sizes, copy number aberrations and 4-mer end motifs in cell-free DNA of hepatocellular carcinoma for enhanced liquid biopsy-based cancer detection.
    Jin C; Liu X; Zheng W; Su L; Liu Y; Guo X; Gu X; Li H; Xu B; Wang G; Yu J; Zhang Q; Bao D; Wan S; Xu F; Lai X; Liu J; Xing J
    Mol Oncol; 2021 Sep; 15(9):2377-2389. PubMed ID: 34133846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blood has never been thicker: Cell-free DNA fragmentomics in the liquid biopsy toolbox of B-cell lymphomas.
    Meriranta L; Pitkänen E; Leppä S
    Semin Hematol; 2023 Jul; 60(3):132-141. PubMed ID: 37455222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leveraging circulating microbial DNA for early cancer detection.
    Kataria R; Shoaie S; Grigoriadis A; Wan JCM
    Trends Cancer; 2023 Nov; 9(11):879-882. PubMed ID: 37659908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systematic biases in reference-based plasma cell-free DNA fragmentomic profiling.
    Liu X; Yang M; Hu D; An Y; Wang W; Lin H; Pan Y; Ju J; Sun K
    Cell Rep Methods; 2024 Jun; 4(6):100793. PubMed ID: 38866008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Challenges and achievements of liquid biopsy technologies employed in early breast cancer.
    Alba-Bernal A; Lavado-Valenzuela R; Domínguez-Recio ME; Jiménez-Rodriguez B; Queipo-Ortuño MI; Alba E; Comino-Méndez I
    EBioMedicine; 2020 Dec; 62():103100. PubMed ID: 33161226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Values of liquid biopsy in early detection of cancer: results from meta-analysis.
    Jia S; Xie L; Li L; Qian Y; Wang J; Wang S; Zhang W; Qian B
    Expert Rev Mol Diagn; 2021 Apr; 21(4):417-427. PubMed ID: 33770449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of mutations in circulating cell-free DNA in relation to disease stage in colorectal cancer.
    Liebs S; Keilholz U; Kehler I; Schweiger C; Haybäck J; Nonnenmacher A
    Cancer Med; 2019 Jul; 8(8):3761-3769. PubMed ID: 31134762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel method for liquid-phase extraction of cell-free DNA for detection of circulating tumor DNA.
    Janku F; Huang HJ; Pereira DY; Kobayashi M; Chiu CH; Call SG; Woodbury KT; Chao F; Marshak DR; Chiu RYT
    Sci Rep; 2021 Oct; 11(1):19653. PubMed ID: 34608196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Limitations and opportunities of technologies for the analysis of cell-free DNA in cancer diagnostics.
    Song P; Wu LR; Yan YH; Zhang JX; Chu T; Kwong LN; Patel AA; Zhang DY
    Nat Biomed Eng; 2022 Mar; 6(3):232-245. PubMed ID: 35102279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ultra-short cell-free DNA fragments enhance cancer early detection in a multi-analyte blood test combining mutation, protein and fragmentomics.
    Wang F; Li X; Li M; Liu W; Lu L; Li Y; Chen X; Yang S; Liu T; Cheng W; Weng L; Wang H; Lu D; Yao Q; Wang Y; Wu J; Wittkop T; Faham M; Zhou H; Hu H; Jin H; Hu Z; Ma D; Cheng X
    Clin Chem Lab Med; 2024 Jan; 62(1):168-177. PubMed ID: 37678194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multi-dimensional cell-free DNA-based liquid biopsy for sensitive early detection of gastric cancer.
    Yu P; Chen P; Wu M; Ding G; Bao H; Du Y; Xu Z; Yang L; Fang J; Huang X; Lai Q; Wei J; Yan J; Yang S; He P; Wu X; Shao Y; Su D; Cheng X
    Genome Med; 2024 Jun; 16(1):79. PubMed ID: 38849905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. When Tissue Is the Issue: Expanding Cell-Free DNA "Liquid Biopsies" to Supernatants and Nonplasma Biofluids.
    Paulson V; Konnick EQ; Lockwood CH
    Clin Lab Med; 2022 Sep; 42(3):485-496. PubMed ID: 36150825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toward the Early Detection of Cancer by Decoding the Epigenetic and Environmental Fingerprints of Cell-Free DNA.
    van der Pol Y; Mouliere F
    Cancer Cell; 2019 Oct; 36(4):350-368. PubMed ID: 31614115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic and prognostic impact of cell-free DNA in human cancers: Systematic review.
    Cervena K; Vodicka P; Vymetalkova V
    Mutat Res Rev Mutat Res; 2019; 781():100-129. PubMed ID: 31416571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating Tumor DNA Assays in Clinical Cancer Research.
    Ossandon MR; Agrawal L; Bernhard EJ; Conley BA; Dey SM; Divi RL; Guan P; Lively TG; McKee TC; Sorg BS; Tricoli JV
    J Natl Cancer Inst; 2018 Sep; 110(9):929-934. PubMed ID: 29931312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bile cell‑free DNA as a novel and powerful liquid biopsy for detecting somatic variants in biliary tract cancer.
    Shen N; Zhang D; Yin L; Qiu Y; Liu J; Yu W; Fu X; Zhu B; Xu X; Duan A; Chen Z; Wang X; Cao X; Zhao T; Zhou Z; Yu L; Qin H; Fang Z; Li JY; Liu Y; Xiong L; Yuan B; Li F; Zhang Y
    Oncol Rep; 2019 Aug; 42(2):549-560. PubMed ID: 31173267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.